The Lamy Center is named in honor of its founder, Peter P. Lamy, PhD, ScD (1925-1994). Its mission is to improve drug therapy for aging adults through innovative research, education, and clinical initiatives.
Improving the lives of older adults by optimizing medication safety and use.
Our Strategic Plan
To learn more about how the Lamy Center's mission to improve drug therapy for aging adults through innovative research, education, and clinical initiatives helps drive its current areas of focus, as well as its direction in the coming years, download the strategic plan.
The Peter Lamy Center on Drug Therapy and Aging recently published its Annual Report for 2018. We encourage visitors to download and explore the report for more information about the clinical, research, and education initiatives in which our faculty and staff were involved throughout 2018.View the Annual Report
Dr. Linda Wastila Receives $1.6 Million Grant from the National Institutes of Health
Study aims to understand how a nationwide effort to reduce the use of antipsychotics in long-term care facilities has impacted use of other medications and patient health outcomes.Learn More
Dr. Barbara J. Zarowitz Publishes "Redefining Quality in Long-Term Care"
Recent publication explores the topic of quality in long-term care and offers insight on how to overcome barriers to achieving quality clinical outcomes in this increasingly demanding sector.Read More
Dr. Nicole Brandt Receives National Award for Leadership in Geriatrics Education
The Dennis W. Jahnigen Memorial Award, presented by the American Geriatrics Society, recognizes individuals who have helped advance geriatrics education across the health professions.Learn More
Celebrating the 40th Anniversary of the Lamy Center
This four-minute video provides an in-depth overview of the Peter Lamy Center on Drug Therapy and Aging, including rare footage of the center's founder, Peter Lamy, PhD, ScD, and interviews with current faculty that offer insight into the future of the center's pioneering work in the field of geriatric pharmacotherapy.